Our Nigerian participants proudly launched their first (virtual) annual scientific conference of Clinical Microbiology and Infectious Diseases Society of Nigeria (CLIMIDSON): “Antimicrobial Stewardship: Time to move from Theory to Practice” on November 26-27, 2020. The state of Antimicrobial Stewardship in Nigeria, the development of antimicrobial policies and treatment guidelines; [...]
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), will take place in Vienna, Austria from 9 – 12 July 2021. Abstracts can be submitted from 11 January to 24 February 2021. Get in touch with us if you would like to submit an abstract on your [...]
Dr. Irma Korinteli, a pediatrician and lecturer at Tbilisi State Medical University, has been involved in the Global-PPS project from the very beginning in 2015. Earlier this year, she successfully defended her PhD on antibiotic use in Georgian hospitals. Read her testimonial below! Working on a PhD was a [...]
In 2021, we will launch a series of webinars in which we will introduce the Global-PPS methodology and discuss updates to the protocol and data entry application. We will further elaborate on the analysis and interpretation of your own data using the Global-PPS export of data in excel as [...]
The Global-PPS protocol has been updated with an optional Healthcare-Associated Infections (HAI) module. This new module allows analyzing additional quality indicators, focusing on the presence of invasive devices. From September till December 2019, the old as well as the new protocol are available for data collection on the wards (transition [...]
Three participants from Brazil, Egypt and The Philippines took a training on hospital-based interventions to contain antibiotic resistance in low-resource setting at the Institute of Tropical Medicine, Antwerp in collaboration with the Laboratory of Medical Microbiology of the University of Antwerp, Belgium. This will allow them to further use their [...]
The Global-PPS moves ahead in 2019! Read more about past events and future plans in our first newsletter.
